Daiwa Securities Group Inc. - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 66 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$04690.0%0.00%
Q2 2023$0
-100.0%
4690.0%0.00%
Q1 2023$10.0%4690.0%0.00%
Q4 2022$1
-99.9%
4690.0%0.00%
Q3 2022$1,000
-96.9%
469
-97.5%
0.00%
Q2 2022$32,000
-56.2%
18,878
-46.8%
0.00%
Q1 2022$73,000
-20.7%
35,516
+44.9%
0.00%
-100.0%
Q4 2021$92,000
+15.0%
24,515
+59.4%
0.00%0.0%
Q3 2021$80,000
+7900.0%
15,382
+5908.6%
0.00%
Q2 2021$1,0000.0%2560.0%0.00%
Q1 2021$1,0000.0%2560.0%0.00%
Q4 2020$1,000256
-20.7%
0.00%
Q3 2019$0
-100.0%
3230.0%0.00%
Q2 2019$1,0000.0%3230.0%0.00%
Q1 2019$1,000
-50.0%
3230.0%0.00%
Q4 2018$2,000
-50.0%
3230.0%0.00%
Q3 2018$4,0000.0%3230.0%0.00%
Q2 2018$4,0000.0%3230.0%0.00%
Q1 2018$4,0003230.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 5,555,461$4,405,4812.16%
MPM BioImpact LLC 5,095,912$4,041,0580.94%
NEA Management Company, LLC 17,079,778$13,544,6240.90%
Syncona Portfolio Ltd 1,377,294$1,092,1940.69%
PFM Health Sciences, LP 10,423,135$8,265,5460.50%
TANG CAPITAL MANAGEMENT LLC 4,387,238$3,479,0800.32%
Long Focus Capital Management, LLC 12,086,915$9,584,9240.32%
Matrix Capital Management Company, LP 38,974,185$30,906,5290.32%
Acuitas Investments, LLC 479,789$380,4730.20%
Key Client Fiduciary Advisors, LLC 336,620$266,9400.16%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders